Stocks and Investing Stocks and Investing
Wed, January 4, 2023
[ 12:00 AM ] - WOPRAI
Tim Nollen Maintained (WBD) at Buy with Decreased Target to $16 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (WCN) at Buy with Decreased Target to $158 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (VERA) at Strong Buy with Decreased Target to $15 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Laura Chico Downgraded (VERA) to Hold and Held Target at $8 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Maury Raycroft Downgraded (VERA) to Hold and Decreased Target to $6 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Saket Kalia Upgraded (VEEV) to Buy and Held Target at $205 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Koji Ikeda Downgraded (BIGC) to Hold and Decreased Target to $11 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
Tessa Romero Initiated (BHVN) at Buy and Held Target at $23 on, Jan 4th, 2023
[ 12:00 AM ] - WOPRAI
RJ Milligan Downgraded (BFS) to Hold on, Jan 4th, 2023
Tue, January 3, 2023
[ 12:00 AM ] - WOPRAI
Travis Steed Upgraded (BDX) to Strong Buy and Increased Target to $290 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Travis Steed Downgraded (BAX) to Hold and Held Target at $55 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jorge Araya Upgraded (BAP) to Buy and Held Target at $156 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vijay Kumar Downgraded (AZTA) to Hold and Increased Target to $62 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Sharpe Maintained (BAH) at Buy with Increased Target to $118 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BAC) at Buy with Decreased Target to $48 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (VCEL) at Stron .. uy with Increased Target to $37 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Upgraded (USB) to Buy and Increased Target to $68 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (WFC) at Buy with Increased Target to $64 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (XOM) at Buy with Increased Target to $129 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Daniel Politzer Upgraded (WYNN) to Buy and Increased Target to $101 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jerome Ramel Downgraded (AAPL) to Hold and Held Target at $140 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Yatin Suneja Upgraded (ACAD) to Strong Buy and Held Target at $22 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (BMY) at Hold with Increased Target to $78 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (BK) at Buy with Increased Target to $64 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $4.5 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vincent Anderson Maintained (ADM) at Strong Buy with Increased Target to $116 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Michael Schmidt Upgraded (ADAP) to Strong Buy and Held Target at $5 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Vijay Kumar Downgraded (ZBH) to Hold and Held Target at $130 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Jason Goldberg Downgraded (ZION) to Sell and Decreased Target to $59 on, Jan 3rd, 2023
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (ASND) at Buy with Increased Target to $177 on, Jan 3rd, 2023

Derek Archila Maintained (ASND) at Buy with Increased Target to $177 on, Jan 3rd, 2023


Published on 2024-10-28 00:43:08 - WOPRAI, Derek Archila
  Print publication without navigation


Derek Archila of Wells Fargo, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $169 to $177 on, Jan 3rd, 2023.

Derek has made no other calls on ASND in the last 4 months.



There are 6 other peers that have a rating on ASND. Out of the 6 peers that are also analyzing ASND, 0 agree with Derek's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Derek

  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Increased Target to $148 on, Tuesday, November 15th, 2022
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $164 on, Monday, November 14th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $148 on, Monday, November 14th, 2022
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $163 on, Thursday, November 3rd, 2022
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Thursday, November 3rd, 2022
  • Paul Choi of "Goldman Sachs" Initiated at Strong Buy and Held Target at $174 on, Thursday, October 20th, 2022
Contributing Sources